2024 Endocrinology Grand Rounds | Polycystic Ovary Syndrome (PCOS): New Guidelines and Basic Principles

Duarte, CA US
March 13, 2024

Polycystic ovary syndrome (PCOS) is a common multifaceted endocrine syndrome with complex origins. There is a need for clinicians to stay abreast of both the diagnosis and treatment of PCOS.
New treatment strategies need to be reviewed, and there is a great need to create awareness of the associated comorbid risks, that in turn may lead to early prevention.  

There is a growing number of referrals for evaluation and treatment of PCOS and obesity. It is imperative to be aware of its many clinical manifestations, including subfertility and insulin resistance.  To adhere with City of Hope's vision to "cure Diabetes", there is a need to address and learn the different pathologies. By learning how PCOS and insulin resistance is associated with diabetes and fatty liver, clinicians will be able to implement early management strategies and get closer to ideal practice, and prevent diabetes.  

Target Audience

Faculty and staff of Department of Diabetes, Endocrinology and Metabolism.

Learning Objectives

  • Identify patients with undiagnosed polycystic ovary syndrome (PCOS) and its associated comorbid conditions within the patient pool.
  • Integrate new knowledge into practice to provide excellent quality of care.
  • Outline the best course of treatment for individual cases.
  • Identify possible new research opportunities.
  • Discuss possible barriers and biases which may impact patient care (i.e., race, ethnicity, language, gender identity/orientation, age, socioeconomic status, attitudes, feelings, or other characteristics).
Activity summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
    City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
    City of Hope designates this 2024 Endocrinology Grand Rounds | Polycystic Ovary Syndrome (PCOS): New Guidelines and Basic Principles for a maximum of 1.00 AMA PRA Category 1 Credit™ requirements. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Attendance
Activity opens: 
03/13/2024
Activity expires: 
03/14/2024
Event starts: 
03/13/2024 - 9:00am PDT
Event ends: 
03/13/2024 - 10:00am PDT
Add to calendar: 
City of Hope
1500 E Duarte Rd
Duarte, CA 91010
United States

Virtual Meeting- Zoom

Daniel A. Dumesic, MD   Professor, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, University of California Los Angeles

Presenter: Dr. Dumesic has indicated the following relevant financial relationships: Consultant for Ferring Pharmaceuticals, Organon, and Spruce Biosciences, Inc. 

Dr. Dumesic will be discussing the off-label or investigational use of Letrozole, Clomiphene, Metformin, Gonadotropins, and Spironolactone.

Planner: Pooja Manroa, MD has indicated that there are no relevant financial relationships.

The educational content has been peer-reviewed, an attestation on file and no conflicts were noted.

CME Committee/Reviewer no relevant financial relationships:  Daneng Li, MD

ACCREDITATION STATEMENT: City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION: City of Hope designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

The following credit type(s) are being offered for this course:

•  AMA PRA Category 1 Credit™  1.0

The following may apply AMA PRA Category 1 Credit™ for license renewal:

Registered Nurses: Nurses may report up to 1.0 credit hours toward the continuing education requirements for license renewal by their state Board of Registered Nurses (BRN). AMA PRA Category 1 Credit™ may be noted on the license renewal application in lieu of a BRN provider number.

Physician Assistants: The National Commission on Certification of Physicians Assistants states that AMA PRA Category 1 Credit™ accredited courses are acceptable for CME requirements for recertification.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
    City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
    City of Hope designates this 2024 Endocrinology Grand Rounds | Polycystic Ovary Syndrome (PCOS): New Guidelines and Basic Principles for a maximum of 1.00 AMA PRA Category 1 Credit™ requirements. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Attendance
Please login or register to take this activity.